|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Loss for the year | |||
| Adjustments to reconcile net profit to net cash provided by operating activities: | |||
| Depreciation and amortization | |||
| Company's share in the loss of a company accounted by equity method, net | |||
| Finance expenses on loans | |||
| Change in the fair value of derivatives | |||
| Share based payments | |||
| Adjustment to Loss due to SPAC transaction | |||
| Increase in trade accounts receivable | |||
| Decrease in contract assets | |||
| Decrease (increase) in inventory | |||
| Decrease (Increase) in other current assets | |||
| Increase (Decrease) in trade payables | |||
| Decrease in ESA prepayments | |||
| Decrease in deferred revenues | |||
| Decrease in other accounts payable and accrued expenses | |||
| Increase in prepayments from customers | |||
| Increase in prepayments from MDA | |||
| Increase (Decrease) in liability for royalties payable | |||
| Agreement with MDA | |||
| Increase in other long-term liabilities | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Decrease (Increase) in long-term bank deposit | |||
| Proceeds from selling a subsidiary | |||
| Proceeds from promissory notes | |||
| Purchase of property, plant and equipment | |||
| Net cash provided (used in) investing activities | |||
| Cash flows from financing activities | |||
| Receipt of long-term loans from banks | |||
| Issuance of warrants to banks | |||
| Receipt of long-term loans from a financial institution | |||
| Repayment of loan to shareholder | |||
| Issuance of warrants to shareholder | |||
| Repayment of loans from banks | |||
| Repayment of royalty liability | |||
| Payments of lease liabilities | |||
| Issuance of shares- SPAC transactions | |||
| Option exercises to shares by employees | |||
| Exercise of warrants, net | |||
| Issuance of shares to FPA | |||
| Net cash provided by financing activities | |||
| Increase in cash and cash equivalents | |||
| Cash and cash equivalents balance at the beginning of the year | |||
| Effect of changes in foreign exchange rates on cash and cash equivalents | |||
| Cash and cash equivalents balance at the end of the year | |||
| Appendix A – Cash paid and received during the year for: | |||
| Interest paid | |||
| Appendix B – Non Cash transactions during the year for: | |||
| Purchase of Fixed Assets in Credit | |||
| Issuance of shares against liability | |||
| Issuance of shares against loan | |||
| Issuance of shares against warrants | |||
| Appendix C – Proceeds from selling a subsidiary | |||
| Cash that was sold | |||
| Prepaid expenses and other | |||
| Short term deposits | |||
| Other accounts receivables | |||
| Property, plant and equipment, net | |||
| Trade accounts payable | |||
| Contract liabilities | |||
| Other accounts payable | |||
| ESA Prepayments | |||
| Related party | |||
| Capital gain | |||
| Capital reserve | |||
| Net assets and liabilities | |||
| Less assets received | |||
| Promissory notes | |||
| Other long-term receivables | |||
| Cash received | |||
| Cash sold | |||
| Net cash inflows |
Loading...